Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?
The search for efficient antimicrobial therapies that can alleviate suffering caused by infections from resistant bacteria is more urgent than ever before. Infections caused by multi-resistant pathogens represent a significant and increasing burden to healthcare and society and researcher are invest...
Main Authors: | Johan Svenson, Natalia Molchanova, Christina I. Schroeder |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.915368/full |
Similar Items
-
Cholic Acid-Based Antimicrobial Peptide Mimics as Antibacterial Agents
by: Jie Wu, et al.
Published: (2022-04-01) -
Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides
by: Denise Bellotti, et al.
Published: (2022-07-01) -
Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria
by: Katrina Browne, et al.
Published: (2023-10-01) -
The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides
by: Joanna Izabela Lachowicz, et al.
Published: (2020-10-01) -
Editorial: Improving antimicrobial peptides translational potential through peptidomimetics
by: Alfredo M. Angeles-Boza, et al.
Published: (2023-10-01)